Crinetics Pharmaceuticals CRNX
CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Selling, General & Administrative (2017 - 2026)

Updated

Crinetics Pharmaceuticals (CRNX) recorded Selling, General & Administrative of $57.57 million in Q2 2026, up 15.5% from $49.84 million a year earlier and up 13.3% from the prior quarter.

Analysis

Crinetics Pharmaceuticals (CRNX) Selling, General & Administrative (2017 - 2026) Analysis & Trends

On a TTM basis, Crinetics Pharmaceuticals' Selling, General & Administrative came in at $214.37 million as of Jun 30, 2026, up 53.7% year-over-year; for FY2025, it came in at $191.33 million, up 91.8% from FY2024.

  • Annual Selling, General & Administrative has increased for nine straight years, with a five-year compound annual growth rate of 60.4% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $99.74 million in FY2024 (+71.7%), $58.09 million in FY2023 (+37.0%), $42.39 million in FY2022 (+72.9%) and $24.53 million in FY2021 (+36.1%).
  • The Q2 2026 figure is the highest quarterly Selling, General & Administrative in data going back to Q2 2017.
  • On a year-over-year basis, Selling, General & Administrative has increased for 33 consecutive quarters, with growth averaging 69.3% over the last eight quarters.
  • Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 15.5% (Q2 2026) to 101.9% (Q3 2025).
  • Per Business Quant, the preceding three quarters came in at $50.83 million (Q1 2026), $53.7 million (Q4 2025) and $52.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn 57.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 57.57 Mn
Mar 31, 2026 50.83 Mn
Dec 31, 2025 53.70 Mn
Sep 30, 2025 52.27 Mn
Jun 30, 2025 49.84 Mn
Mar 31, 2025 35.53 Mn
Dec 31, 2024 28.18 Mn
Sep 30, 2024 25.89 Mn
Jun 30, 2024 24.84 Mn
Mar 31, 2024 20.83 Mn
Dec 31, 2023 17.08 Mn
Sep 30, 2023 15.48 Mn
Jun 30, 2023 13.34 Mn
Mar 31, 2023 12.19 Mn
Dec 31, 2022 11.27 Mn
Sep 30, 2022 11.93 Mn
Jun 30, 2022 10.49 Mn
Mar 31, 2022 8.71 Mn
Dec 31, 2021 7.36 Mn
Sep 30, 2021 6.23 Mn
API Access

Crinetics Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CRNX&period=max&api_key=YOUR_API_KEY